ReviewSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2026
[Advances in deep learning multimodal fusion for early diagnosis of knee osteoarthritis].
Review in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Knee osteoarthritis (KOA) is a common chronic degenerative disease that causes pain, functional limitation, and reduced quality of life in middle-aged and elderly populations. Early KOA is characterized by relatively subtle symptomatic, structural, and functional changes, including knee pain or stiffness, cartilage matrix alterations, meniscal degeneration, bone marrow lesions, and mild abnormalities in load-related function, while radiographic findings may remain atypical. A single imaging modality or clinical indicator is therefore insufficient to characterize the early pathological status of KOA. Deep learning (DL)-based multimodal fusion can integrate X-ray, magnetic resonance imaging, clinical variables, gait/biomechanical data, and potential molecular biomarkers, supporting early identification and risk stratification from the perspectives of bony structure, soft-tissue change, symptom burden, and functional loading. This review summarizes multimodal data types, preprocessing and feature extraction methods, early/intermediate/late fusion strategies, representative DL architectures, and current application evidence for early KOA diagnosis. We further discuss key translational issues, including cost-effectiveness, label consistency, center effects, missing modalities, and multimodal interpretability. Current evidence suggests that multimodal fusion may provide incremental value over unimodal approaches, but its clinical utility requires further confirmation through unified early-stage definitions, standardized acquisition, multi-reader consensus annotation, and multicenter external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.